Effect of fenofibrate on plasma apolipoprotein C-III levels: a systematic review and meta-analysis of randomised placebo-controlled trials.

Amirhossein SahebkarLuis E Simental-MendíaNiki KatsikiŽeljko ReinerMaciej BanachMatteo PirroStephen L Atkin

Published in: BMJ open (2019)

This meta-analysis found that fenofibrate therapy significantly decreases apo C-III levels, an effect evident with both short-term treatment and doses less than 200 mg/day.

Keyphrases

placebo controlled
systematic review
double blind
clinical trial
study protocol
open label
meta analyses
stem cells
phase iii
phase ii
randomized controlled trial
squamous cell carcinoma
phase ii study
rectal cancer